Delivery Order SPE2DB20D2002-SPE2DB25FL38A
- Not listed
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,870.10 on August 4, 2025, for the supply of IPOL Vial 5ML pharmaceutical product. The contract is a firm fixed price delivery order with an ultimate completion date of August 5, 2025, and represents a non-set-aside competitive award. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $54,368.42 to AmerisourceBergen Drug Corp for the supply of IPOL vial 5ML, a poliomyelitis vaccine product. This firm fixed price, competitively awarded delivery order was issued on September 2, 2025, with an ultimate completion date of September 3, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's broader...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $2,094.49 for IPOL vials (5mL) on July 15, 2025, with completion expected by July 16, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child contract, this delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $38,677.88 to AmerisourceBergen Drug Corp for the supply of IPOL Vial 5ML pharmaceutical products. This firm fixed-price, competitively awarded delivery order was issued on July 23, 2025, with an ultimate completion date of July 24, 2025, and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, indicating AmerisourceBergen Drug Corp...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,090.10 to AmerisourceBergen Drug Corp for a 5mL vial of Ipol (polio vaccine) on July 22, 2025, with an ultimate completion date of July 23, 2025. This delivery order was competitively awarded with firm fixed pricing and no set-aside designation. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate office. This delivery order is a child contract issued...
- The Defense Logistics Agency awarded a delivery order valued at $17,441.60 to AmerisourceBergen Drug Corp for IPOL Vial 5ML, an inactivated polio vaccine product. Issued on April 24, 2025, with completion scheduled for April 25, 2025, this firm fixed-price delivery order represents a competitively awarded contract with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Ipol Vial 5ML, a poliomyelitis vaccine product. This firm fixed price delivery order has a ceiling value of $31,302.96 and an ultimate completion date of August 22, 2025, with no set-aside designation. The contract represents a non-competitive award made under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued...
- The Defense Logistics Agency awarded a $2,307.21 delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Ipol Vial 5ML, a polio vaccine product. This firm fixed-price, non-set-aside contract is scheduled for completion by August 20, 2025, with performance at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The delivery order represents a pediatric immunization pharmaceutical requirement within the federal medical supply chain. This award is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of IPOL vial 5ML pharmaceutical product, with a ceiling value of $1,544.12. This competitive award, issued on September 14, 2025, with an ultimate completion date of September 15, 2025, represents a firm fixed price delivery order with no set-aside designation. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $80,074.43 by the Defense Logistics Agency on July 17, 2025, for the supply of Ipol vial 5ml pharmaceutical products. The contract utilizes firm fixed pricing and is classified as a non-set-aside competitive award, with an ultimate completion date of July 18, 2025. Performance will be executed from the contractor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order operates as a child contract under...
- SPE2DB20D2002Indefinite Delivery Contract
- SPE2DB20D2002-SPE2DB25FL38ADelivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $36,690.60 by the Defense Logistics Agency for the supply of Ipol vial 5ml on April 24, 2025, with an ultimate completion date of April 25, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's Conshohocken facility. Ipol is an inactivated polio vaccine used within military and federal healthcare systems to support immunization requirements across the Department of Defense. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime indefinite delivery vehicle provides comprehensive global pharmaceutical support, enabling AmerisourceBergen to supply a broad range of pharmaceutical products, medical supplies, vaccines, and specialty medications to support military healthcare programs and other federal healthcare systems worldwide, including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $36.7k | 4/24/25 |